Presage Technologies Earns FDA Clearance for Contactless Vital Signs, Makes Them Available for Free

FDA-cleared camera-based vital signs platform offers heart rate and breathing rate at no cost to hospitals, clinics, health organizations, and educators.

WASHINGTON, July 7, 2026 /PRNewswire/ — Presage Technologies announced today that SmartSpectra Vital Signs Monitor 1.0 SDK has received FDA 510(k) clearance (K254169) for iOS and Android — and is making those cleared metrics free. Hospitals, clinics, global health organizations, and educational institutions can now access FDA-cleared contactless pulse rate and breathing rate monitoring using a mobile device camera, at zero cost.

The FDA-cleared SmartSpectra measurement for iOS and Android requires no wearable sensors, physical contact, or specialized hardware. Separately, the broader SmartSpectra SDK platform is available across Mac, Linux, Windows, iOS, and Android, giving developers, businesses, and organizations access to contactless vital signs and remote health monitoring tools. The broader platform can also capture uncalibrated arterial pressure waveforms, breathing waveforms, heart rate variability, and facial expression analytics.

Sign up for Blog Updates